SearchDictionaryMobileLogin

Gonadal hormones and frontocortical expression of vascular endothelial growth factor in male stroke-prone, spontaneously hypertensive rats, a model for attention-deficit/hyperactivity disorder.

AbstractAttention-deficit/hyperactivity disorder (AD/HD) is a common pediatric behavioral disorder associated, in part, with male preponderance and reduced regional cerebral blood flow (rCBF). However, mechanism(s) underlying male preponderance and reduced rCBF in AD/HD are unclear. The present study profiles the expression of angiogenic and hormonal factors likely to underlie these symptoms using a recently characterized AD/HD animal model, juvenile male stroke-prone spontaneously hypertensive rats (SHRSP). Because vascular endothelial growth factor (VEGF) signaling cascade and gonadal steroids are key regulators of angiogenesis and gender-based behavior, respectively, we profiled their patterns of expression in the frontal cortex of SHRSP to elucidate their roles in the genesis of AD/HD male preponderance and rCBF. Interestingly, levels of VEGF, VEGF receptors (KDR, Flt-1), endothelial nitric oxide synthase, phosphorylated Akt (pAkt), estrogen receptor-alpha, aromatase, and capillary density in sham-operated SHRSP were remarkably down-regulated, whereas androgen receptor levels were up-regulated, compared with age-matched genetic control, Wistar-Kyoto rats. Castration, estrogen, and androgen receptor antagonist (flutamide) counteracted these effects. Dihydrotestosterone, but not testosterone, reversed the beneficiary effects of castration. Estrogen receptor-beta levels remained unchanged in all groups examined. We postulate that changes in androgen metabolism that tend to up-regulate local dihydrotestosterone concentration and diminish estrogen synthesis, in the frontal cortex of juvenile male SHRSP, may lower levels and/or activity of VEGF and its signaling cascade and, subsequently, reduce rCBF. These findings could, in part, help explain the pathogenesis of reduced rCBF and male preponderance in AD/HD.
AuthorsSubrina Jesmin, Hiroko Togashi, Ichiro Sakuma, Chishimba N Mowa, Ken-Ichi Ueno, Taku Yamaguchi, Mitsuhiro Yoshioka, Akira Kitabatake (Affiliation: Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan.)
JournalEndocrinology (Endocrinology) Vol. 145 Issue 9 Pg. 4330-43 (Sep 2004) ISSN: 0013-7227 United States
PMID15178644 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • Estrogens
  • Gonadal Steroid Hormones
  • Proto-Oncogene Proteins
  • Receptors, Androgen
  • Receptors, Estrogen
  • Vascular Endothelial Growth Factor A
  • Nitric Oxide
  • Dihydrotestosterone
  • Testosterone
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat
  • Aromatase
  • Vascular Endothelial Growth Factor Receptor-1
  • Vascular Endothelial Growth Factor Receptor-2
  • Akt1 protein, rat
  • Proto-Oncogene Proteins c-akt
  • Protein-Serine-Threonine Kinases
Topics
  • Animals
  • Aromatase (genetics)
  • Attention Deficit Disorder with Hyperactivity (physiopathology)
  • Capillaries (physiology)
  • Cerebrovascular Circulation (physiology)
  • Dihydrotestosterone (blood)
  • Disease Models, Animal
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • Estrogens (blood)
  • Frontal Lobe (blood supply)
  • Gonadal Steroid Hormones (blood)
  • Hypertension (physiopathology)
  • Male
  • Nitric Oxide (metabolism)
  • Nitric Oxide Synthase (genetics)
  • Nitric Oxide Synthase Type III
  • Protein-Serine-Threonine Kinases (genetics)
  • Proto-Oncogene Proteins (genetics)
  • Proto-Oncogene Proteins c-akt
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Receptors, Androgen (genetics)
  • Receptors, Estrogen (genetics)
  • Signal Transduction (physiology)
  • Stroke (physiopathology)
  • Testosterone (blood)
  • Vascular Endothelial Growth Factor A (genetics)
  • Vascular Endothelial Growth Factor Receptor-1 (genetics)
  • Vascular Endothelial Growth Factor Receptor-2 (genetics)